Literature DB >> 26351397

Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.

Gregory Y H Lip1, Deirdre A Lane2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26351397     DOI： 10.1093/eurheartj/ehv415

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

Review 1.  Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.

Authors:  Amish N Raval; Joaquin E Cigarroa; Mina K Chung; Larry J Diaz-Sandoval; Deborah Diercks; Jonathan P Piccini; Hee Soo Jung; Jeffrey B Washam; Babu G Welch; Allyson R Zazulia; Sean P Collins
Journal:  Circulation       Date:  2017-02-06       Impact factor: 29.690

2.  Impact of longitudinal data-completeness of electronic health record data on risk score misclassification.

Authors:  Yinzhu Jin; Sebastian Schneeweiss; Dave Merola; Kueiyu Joshua Lin
Journal:  J Am Med Inform Assoc       Date:  2022-06-14       Impact factor: 7.942

Review 3.  Emerging Tools for Stroke Prevention in Atrial Fibrillation.

Authors:  Christos Voukalis; Gregory Y H Lip; Eduard Shantsila
Journal:  EBioMedicine       Date:  2016-01-15       Impact factor: 8.143

4.  Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

Authors:  Amaya García-Fernández; Vanessa Roldán; José Miguel Rivera-Caravaca; Diana Hernández-Romero; Mariano Valdés; Vicente Vicente; Gregory Y H Lip; Francisco Marín
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

5.  Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation.

Authors:  José Miguel Rivera-Caravaca; Vanessa Roldán; María Asunción Esteve-Pastor; Mariano Valdés; Vicente Vicente; Gregory Y H Lip; Francisco Marín
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

6.  A Delphi consensus on the management of oral anticoagulation in patients with non-valvular atrial fibrillation in Spain: ACOPREFERENCE study.

Authors:  Carlos Escobar; Xavier Borrás; Ramón Bover Freire; Carlos González-Juanatey; Miren Morillas; Alfonso Valle Muñoz; Juan José Gómez-Doblas
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

7.  A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction.

Authors:  Hao Li; Yuan Cui; Jin Tian; Hong Yang; Qing Zhang; Ke Wang; Qinghua Han; Yanbo Zhang
Journal:  Open Med (Wars)       Date:  2020-07-10

8.  Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores.

Authors:  Marco Proietti; Keitaro Senoo; Deirdre A Lane; Gregory Y H Lip
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

9.  Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores.

Authors:  Marco Proietti; José Miguel Rivera-Caravaca; María Asunción Esteve-Pastor; Giulio Francesco Romiti; Francísco Marin; Gregory Y H Lip
Journal:  J Am Heart Assoc       Date:  2018-09-18       Impact factor: 5.501

10.  Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.

Authors:  Jose María Mostaza; Carmen Suarez; Jose María Cepeda; Luis Manzano; Demetrio Sánchez
Journal:  BMC Cardiovasc Disord       Date:  2021-08-09       Impact factor: 2.298
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.